Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph early_phase_1
1
9%
Ph phase_1
7
64%
Ph phase_2
1
9%
Ph phase_4
1
9%

Phase Distribution

8

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Early Phase 1First-in-human
1(10.0%)
Phase 1Safety & dosage
7(70.0%)
Phase 2Efficacy & side effects
1(10.0%)
Phase 4Post-market surveillance
1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Active(1)
Completed(3)
Other(7)

Detailed Status

unknown7
Completed3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (10.0%)
Phase 17 (70.0%)
Phase 21 (10.0%)
Phase 41 (10.0%)

Trials by Status

not_yet_recruiting19%
unknown764%
completed327%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
11